HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies

NCT06649708 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor Malignancies

Interventions

DRUG: HX044

Sponsor

Hanx Biopharmaceuticals (Wuhan) Co., Ltd.